N-cyclohexyl-6-[8-[4-(4,5,9,13-tetramethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl)phenyl]-2-azaspiro[4.5]decan-2-yl]pyridazine-3-carboxamide;4-hydroxy-2-methoxybenzonitrile

C46H53N9O3S — CID 176992889

IUPACN-cyclohexyl-6-[8-[4-(4,5,9,13-tetramethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl)phenyl]-2-azaspiro[4.5]decan-2-yl]pyridazine-3-carboxamide;4-hydroxy-2-methoxybenzonitrile
SMILESCOc1cc(O)ccc1C#N.Cc1sc2c(c1C)C(c1ccc(C3CCC4(CC3)CCN(c3ccc(C(=O)NC5CCCCC5)nn3)C4)cc1)=NC(C)c1nnc(C)n1-2
InChIInChI=1S/C38H46N8OS.C8H7NO2/c1-23-25(3)48-37-33(23)34(39-24(2)35-44-41-26(4)46(35)37)29-12-10-27(11-13-29)28-16-18-38(19-17-28)20-21-45(22-38)32-15-14-31(42-43-32)36(47)40-30-8-6-5-7-9-30;1-11-8-4-7(10)3-2-6(8)5-9/h10-15,24,28,30H,5-9,16-22H2,1-4H3,(H,40,47);2-4,10H,1H3
InChIKeyAFYXKAPYLIAMBX-UHFFFAOYSA-N
MW812.06 g/mol
LogP8.85
Rot. Bonds6

About N-cyclohexyl-6-[8-[4-(4,5,9,13-tetramethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl)phenyl]-2-azaspiro[4.5]decan-2-yl]pyridazine-3-carboxamide;4-hydroxy-2-methoxybenzonitrile

N-cyclohexyl-6-[8-[4-(4,5,9,13-tetramethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl)phenyl]-2-azaspiro[4.5]decan-2-yl]pyridazine-3-carboxamide;4-hydroxy-2-methoxybenzonitrile (PubChem CID 176992889) has the molecular formula C46H53N9O3S and a molecular weight of 812.06 g/mol. Its IUPAC name is N-cyclohexyl-6-[8-[4-(4,5,9,13-tetramethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl)phenyl]-2-azaspiro[4.5]decan-2-yl]pyridazine-3-carboxamide;4-hydroxy-2-methoxybenzonitrile.

Molecular Properties

Compound NameN-cyclohexyl-6-[8-[4-(4,5,9,13-tetramethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl)phenyl]-2-azaspiro[4.5]decan-2-yl]pyridazine-3-carboxamide;4-hydroxy-2-methoxybenzonitrile
PubChem CID176992889
Molecular FormulaC46H53N9O3S
Molecular Weight812.06 g/mol
Exact Mass811.40
IUPAC NameN-cyclohexyl-6-[8-[4-(4,5,9,13-tetramethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl)phenyl]-2-azaspiro[4.5]decan-2-yl]pyridazine-3-carboxamide;4-hydroxy-2-methoxybenzonitrile
SMILESCOc1cc(O)ccc1C#N.Cc1sc2c(c1C)C(c1ccc(C3CCC4(CC3)CCN(c3ccc(C(=O)NC5CCCCC5)nn3)C4)cc1)=NC(C)c1nnc(C)n1-2
InChIInChI=1S/C38H46N8OS.C8H7NO2/c1-23-25(3)48-37-33(23)34(39-24(2)35-44-41-26(4)46(35)37)29-12-10-27(11-13-29)28-16-18-38(19-17-28)20-21-45(22-38)32-15-14-31(42-43-32)36(47)40-30-8-6-5-7-9-30;1-11-8-4-7(10)3-2-6(8)5-9/h10-15,24,28,30H,5-9,16-22H2,1-4H3,(H,40,47);2-4,10H,1H3
InChIKeyAFYXKAPYLIAMBX-UHFFFAOYSA-N
XLogP8.85
TPSA154.44 Ų
H-Bond Donors2
H-Bond Acceptors12
Rotatable Bonds6
Heavy Atoms59
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500812.06
LogP ≤ 58.85
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1012

Analyze N-cyclohexyl-6-[8-[4-(4,5,9,13-tetramethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl)phenyl]-2-azaspiro[4.5]decan-2-yl]pyridazine-3-carboxamide;4-hydroxy-2-methoxybenzonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-cyclohexyl-6-[8-[4-(4,5,9,13-tetramethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl)phenyl]-2-azaspiro[4.5]decan-2-yl]pyridazine-3-carboxamide;4-hydroxy-2-methoxybenzonitrile?
The IUPAC name of N-cyclohexyl-6-[8-[4-(4,5,9,13-tetramethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl)phenyl]-2-azaspiro[4.5]decan-2-yl]pyridazine-3-carboxamide;4-hydroxy-2-methoxybenzonitrile (CID 176992889) is N-cyclohexyl-6-[8-[4-(4,5,9,13-tetramethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl)phenyl]-2-azaspiro[4.5]decan-2-yl]pyridazine-3-carboxamide;4-hydroxy-2-methoxybenzonitrile.
What is the SMILES notation for N-cyclohexyl-6-[8-[4-(4,5,9,13-tetramethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl)phenyl]-2-azaspiro[4.5]decan-2-yl]pyridazine-3-carboxamide;4-hydroxy-2-methoxybenzonitrile?
The canonical SMILES for N-cyclohexyl-6-[8-[4-(4,5,9,13-tetramethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl)phenyl]-2-azaspiro[4.5]decan-2-yl]pyridazine-3-carboxamide;4-hydroxy-2-methoxybenzonitrile is COc1cc(O)ccc1C#N.Cc1sc2c(c1C)C(c1ccc(C3CCC4(CC3)CCN(c3ccc(C(=O)NC5CCCCC5)nn3)C4)cc1)=NC(C)c1nnc(C)n1-2.
What is the InChIKey of N-cyclohexyl-6-[8-[4-(4,5,9,13-tetramethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl)phenyl]-2-azaspiro[4.5]decan-2-yl]pyridazine-3-carboxamide;4-hydroxy-2-methoxybenzonitrile?
The InChIKey is AFYXKAPYLIAMBX-UHFFFAOYSA-N. The full InChI is InChI=1S/C38H46N8OS.C8H7NO2/c1-23-25(3)48-37-33(23)34(39-24(2)35-44-41-26(4)46(35)37)29-12-10-27(11-13-29)28-16-18-38(19-17-28)20-21-45(22-38)32-15-14-31(42-43-32)36(47)40-30-8-6-5-7-9-30;1-11-8-4-7(10)3-2-6(8)5-9/h10-15,24,28,30H,5-9,16-22H2,1-4H3,(H,40,47);2-4,10H,1H3.
What are the key properties of N-cyclohexyl-6-[8-[4-(4,5,9,13-tetramethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl)phenyl]-2-azaspiro[4.5]decan-2-yl]pyridazine-3-carboxamide;4-hydroxy-2-methoxybenzonitrile?
N-cyclohexyl-6-[8-[4-(4,5,9,13-tetramethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl)phenyl]-2-azaspiro[4.5]decan-2-yl]pyridazine-3-carboxamide;4-hydroxy-2-methoxybenzonitrile has a molecular weight of 812.06 g/mol, XLogP of 8.85, 6 rotatable bonds, 2 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for N-cyclohexyl-6-[8-[4-(4,5,9,13-tetramethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl)phenyl]-2-azaspiro[4.5]decan-2-yl]pyridazine-3-carboxamide;4-hydroxy-2-methoxybenzonitrile is sourced from PubChem (CID 176992889), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).